Description

Mematon IC (memantine) Coated Tablets 20 mg. №30

Ingredients:

Each coated tablet contains 20 mg of memantine hydrochloride.

Dosage:

The recommended dosage is one 20 mg tablet per day. It is important to follow the instructions provided by your healthcare provider.

Indications:

Mematon IC is indicated for the treatment of moderate to severe Alzheimer’s disease. It helps improve memory, attention, reason, language, and the ability to perform simple tasks.

Contraindications:

Do not use Mematon IC if you are allergic to memantine or any other ingredients in the product. Consult your doctor before starting this medication if you have kidney problems.

Directions:

Take Mematon IC exactly as prescribed by your doctor. Swallow the tablet whole with water, with or without food.

Scientific Evidence:

Memantine, the active ingredient in Mematon IC, works by regulating the activity of glutamate, a neurotransmitter involved in learning and memory. Studies have shown that memantine can help slow down the progression of Alzheimer’s disease by protecting brain cells from excess glutamate. Research published in the Journal of Alzheimer’s Disease demonstrated that memantine treatment was associated with improved cognitive function and daily living activities in patients with Alzheimer’s disease.

Additional Information:

Mematon IC has been well-tolerated in clinical trials, with common side effects including headache, constipation, and dizziness. It is important to inform your healthcare provider of any side effects experienced while taking this medication. Remember to store Mematon IC at room temperature away from moisture and heat.

Mematon IC (memantine) is a widely used medication for the treatment of Alzheimer’s disease. It is known for its ability to improve cognitive function and slow down the progression of the disease. The pharmacological action of memantine involves blocking the activity of glutamate, a neurotransmitter that can cause damage to brain cells when present in excess.

Clinical trials have shown that Mematon IC is effective in improving memory, attention, and overall cognitive function in patients with Alzheimer’s disease. Compared to similar drugs, memantine has been found to have a favorable side effect profile and is well-tolerated by most patients. It is considered a valuable treatment option for individuals suffering from moderate to severe Alzheimer’s disease.